Your browser doesn't support javascript.
loading
Is ultra-thin Descemet stripping automated endothelial keratoplasty a viable alternative to Descemet membrane endothelial keratoplasty? A systematic review and meta-analysis.
Singh, Tanu; Ichhpujani, Parul; Singh, Rohan Bir; Arya, Sudesh; Kumar, Suresh.
Afiliación
  • Singh T; Assistant Professor, Department of Ophthalmology, Government Medical College and Hospital, Sector-32, Chandigarh 160030, India.
  • Ichhpujani P; Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India.
  • Singh RB; Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
  • Arya S; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
  • Kumar S; Discipline of Ophthalmology and Visual Sciences, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.
Ther Adv Ophthalmol ; 15: 25158414221147823, 2023.
Article en En | MEDLINE | ID: mdl-36776476
ABSTRACT

Background:

Ultra-thin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) is a recently developed surgical procedure that has shown promising results for the management of various corneal endothelial diseases.

Objectives:

To evaluate the outcomes of the UT-DSAEK to the Descemet membrane endothelial keratoplasty (DMEK).

Design:

A systematic analysis of the studies comparing UT-DSAEK with DMEK by evaluating one or more outcomes (vision, complications, and post-operative endothelial cell counts) was performed. The meta-analysis was done if two or more studies reported a common outcome.

Methods:

We used PubMed, EMBASE, and SCOPUS databases to identify articles comparing the outcomes of UT-DSAEK with DMEK and performed a meta-analysis using RevMan, version 5.4.

Results:

A total of six studies were included in this review (two randomized clinical trials and four non-randomized comparative studies). Our analysis showed the patients who underwent DMEK cases showed better visual outcomes with a mean difference of 0.06 LogMAR (95% CI 0.04-0.09) in BCVA, albeit with i 2 of 52% (heterogenous values). The evidence was weak, with the most weightage on retrospective studies. UT-DSAEK showed significantly fewer complications such as graft dislocations, with an odds ratio of 0.25 (95% CI 0.13-0.48). There was no significant difference in the endothelial cell counts with a mean difference of 86.34 (95%CI -133.09 to -305.77).

Conclusion:

Although the literature is limited on UT-DSAEK with post-operative visual acuity that could be practically at par with DMEK, lesser complication rates and comparable post-operative endothelial cells could be a suitable alternative to DMEK for corneal endothelial pathologies.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Systematic_reviews Idioma: En Revista: Ther Adv Ophthalmol Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Systematic_reviews Idioma: En Revista: Ther Adv Ophthalmol Año: 2023 Tipo del documento: Article País de afiliación: India